Efficacy and Safety of Vildagliptin as add-on Therapy to Insulin in Patients With Type 2 Diabetes Mellitus

NCT01224366 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

448

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Vildagliptin
DRUG: Placebo

Sponsor

Novartis